“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  STE

STERIS PLC

LISTEDNYSE
SYMBOLSTE
SIC3842
STATE OF INC.L2
FISCAL YEAR ENDSMarch 31
CIK1757898

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2017–2026

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions02462017201820192020202120222023202420252026RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.002.004.006.008.002017201820192020202120222023202420252026EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 3/31/26

($ millions)Amount%
Total debt1,93221.2
Stockholders' equity7,18478.8
Total capitalization9,115100.0

97,500,110 shares outstanding at 4 August 2026 (cover page of the 10-Q filed 7 August 2026).

LONG-TERM DEBT 3/31/26

($ millions)Amount
Long-term debt, incl. current maturities1,813
Long-term debt, noncurrent1,813
Short-term borrowings / commercial paper119

CAPITAL STOCK 3/31/26

Common shares authorized500,000,000
Common shares issued97,800,000
Par or stated value per share ($)0.001
Outstanding at 8/4/2697,500,110

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20262.4631.0
20252.2336.0
20242.0353.3
20231.84172.0
20221.6968.1

HISTORY AND BUSINESS

HISTORY: Incorporated in Ireland. Formerly known as STERIS Ltd (to 28 March 2019).

BUSINESS: Classified by the SEC under Standard Industrial Classification 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. Large accelerated filer. Principal executive office: 70 Sir John Rogerson'S Quay, Dublin, L2 2. Fiscal year ends March 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)3/31/263/31/253/31/24
Revenues5,9365,4605,139
Cost of revenues3,3093,0572,920
Gross profit2,6262,4032,218
Research and development113108104
Selling, general and administrative1,4081,3341,252
Depreciation and amortization486476565
Operating income1,102867836
Interest expense6186144
Income before income taxes1,047796703
Income taxes262185150
Net income782615378
Earned per share, diluted ($)7.936.203.81
Dividends per share ($)2.462.232.03

CONSOLIDATED BALANCE SHEET

($ millions)3/31/263/31/25
Receivables, net1,0931,044
Inventories632581
Total current assets2,3952,001
Property, plant and equipment, net2,1611,956
Goodwill4,1954,096
Total assets10,73710,147
Total current liabilities1,1451,022
Long-term debt1,8131,919
Total liabilities3,5403,531
Stockholders' equity7,1846,603
Total liabilities and equity10,73710,147

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
3/31/265,9361,10278213.27.932.461,34136997210,7373,5401,9327,18410.90.27
3/31/255,46086761511.36.202.231,14837077810,1473,5312,0446,6039.30.31
3/31/245,1398363787.43.812.0397336061311,0644,7483,2066,3026.00.51
3/31/234,5367911072.41.071.8475736239510,8224,7353,0796,0771.80.51
3/31/224,2234782445.82.481.6968528839711,4244,8793,0886,5323.70.47
3/31/213,10854839712.84.631.576902394506,5742,6831,6513,88110.20.43
3/31/203,03153740813.54.761.455912153765,4412,0231,1513,40512.00.34
3/31/192,78241130410.93.551.335401903505,0731,8871,1833,1789.60.37
3/31/182,62040029111.13.391.214581652925,2001,9831,3163,2069.10.41
3/31/172,6132261104.21.281.09424173251–––2,8103.9–

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

STERIS plc
CIK 1757898 · EIN 00-0000000

PRINCIPAL OFFICE:

70 Sir John Rogerson'S Quay, Dublin, L2 2
Tel.: 35312322000

INCORPORATED:

Ireland

INDUSTRY (SEC SIC CODE):

3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 3/31/26, filed 29 May 2026

FORMER NAMES:

STERIS Ltd

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/13/268-Kperiod 10/11/26
8/7/2610-Qperiod 6/30/26
8/6/268-Kperiod 7/31/26
8/5/268-Kperiod 8/5/26
6/11/26DEF 14Aperiod 7/31/26
5/29/2610-Kperiod 3/31/26
5/11/268-Kperiod 5/11/26
5/7/268-Kperiod 5/1/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2026 (filed 5/29/26) · 10-K FY2025 (filed 5/29/25) · 10-K FY2024 (filed 5/29/24) · 10-K FY2023 (filed 5/26/23) · 10-K FY2022 (filed 5/31/22) · 10-K FY2021 (filed 5/28/21) · 10-K FY2020 (filed 5/29/20) · 10-K FY2019 (filed 5/30/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice